Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$62.68 - $95.05 $13,538 - $20,530
216 Added 2.85%
7,788 $731,000
Q1 2023

May 15, 2023

SELL
$47.19 - $70.77 $6,465 - $9,695
-137 Reduced 1.78%
7,572 $513,000
Q4 2022

Feb 13, 2023

SELL
$30.35 - $53.15 $18,361 - $32,155
-605 Reduced 7.28%
7,709 $381,000
Q3 2022

Nov 09, 2022

BUY
$31.97 - $49.37 $42,584 - $65,760
1,332 Added 19.08%
8,314 $270,000
Q2 2022

Aug 12, 2022

BUY
$35.61 - $76.23 $14,920 - $31,940
419 Added 6.38%
6,982 $275,000
Q1 2022

May 16, 2022

BUY
$57.56 - $82.54 $346,683 - $497,138
6,023 Added 1115.37%
6,563 $458,000
Q4 2021

Feb 14, 2022

BUY
$72.5 - $100.68 $39,150 - $54,367
540 New
540 $42,000
Q3 2019

Jan 08, 2024

SELL
$90.37 - $122.49 $81.3 Million - $110 Million
-900,000 Closed
0 $0
Q2 2019

Jan 08, 2024

BUY
$89.51 - $118.04 $80.6 Million - $106 Million
900,000 New
900,000 $9.09 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Snowden Capital Advisors LLC Portfolio

Follow Snowden Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Snowden Capital Advisors LLC with notifications on news.